CVS Health Corp
CVS- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0000064803
No open-market purchases or sales by CVS Health Corp insiders were filed in the last 90 days; 2,074 institutions reported holding it in 13F filings for Q2 2026, worth $117.5B in total; 3 superinvestors hold it, including Viking Global Investors and Fairfax Financial.
Superinvestors holding CVS, Q2 2026
3 superinvestors report holding CVS Health Corp on Form 13F, worth $694.2M in total. Weight is CVS Health Corp's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | 1.1% | 3,663,361 | $379.0M | New |
| Fairfax FinancialPrem Watsa | 10.6% | 2,712,000 | $280.5M | Unchanged |
| Harris Associates (Oakmark)Bill Nygren | <0.1% | 335,817 | $34.7M | Reduced−32.0% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CVS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
3 superinvestors holding at quarter end
- New
- Viking Global Investors
- Reduced
- Harris Associates (Oakmark) (−32.0%)
- Sold out
- Maverick Capital
Q1 2026
3 superinvestors holding at quarter end
- New
- Maverick Capital
- Reduced
- Harris Associates (Oakmark) (−5.9%)
Q4 2025
2 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−4.3%)
Q3 2025
2 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−35.0%)
Q2 2025
2 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−85.9%)
Q1 2025
2 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+5.0%)
Q4 2024
2 superinvestors holding at quarter end
- New
- Fairfax Financial
- Reduced
- Harris Associates (Oakmark) (−0.9%)
- Sold out
- Third Point
Q3 2024
2 superinvestors holding at quarter end
- New
- Third Point
- Added
- Harris Associates (Oakmark) (+21.9%)
- Sold out
- Markel Group
Q2 2024
2 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+9.3%)
- Reduced
- Markel Group (−85.8%)
- Sold out
- Fairfax Financial
Q1 2024
3 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+4.0%)
Q4 2023
3 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+6.2%)
- Sold out
- Gates Foundation Trust, Maverick Capital
Q3 2023
5 superinvestors holding at quarter end
- New
- Gates Foundation Trust
- Added
- Harris Associates (Oakmark) (+287.3%), Maverick Capital (+43.9%)
Q2 2023
4 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+3.1%), Maverick Capital (+127.8%)
Q1 2023
4 superinvestors holding at quarter end
- Added
- Maverick Capital (+168.9%)
- Reduced
- Harris Associates (Oakmark) (−1.5%)
Q4 2022
4 superinvestors holding at quarter end
- New
- Maverick Capital
- Reduced
- Harris Associates (Oakmark) (−9.9%)
Q3 2022
3 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−7.2%)
Q2 2022
3 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−71.4%), Fairfax Financial (−43.4%)
Q1 2022
3 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−41.4%)
Q4 2021
3 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−12.0%)
Q3 2021
3 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (−5.5%)
Q2 2021
3 superinvestors holding at quarter end
- Reduced
- Harris Associates (Oakmark) (0.0%)
- Sold out
- Maverick Capital